Nutrition and Pharmacological Algorithm for Oncology Patients Study

Stopped early · Phase 4

Conditions studied: Oncologic Complications, Quality of Life, Nutrition Poor, Head and Neck Cancer, Lung Cancer, Pancreatic Cancer

In brief

Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatment and improve the quality of life of patients by implementing an algorithm utilizing nutrition intervention and appetite stimulants.

Key facts

Study ID

NCT04155008

Run by

Montefiore Medical Center

People needed

1

Starts

2021-03-01

Expected to finish

2021-04-05

Last updated by the study team

2022-11-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of head/neck, lung, pancreatic cancer, or metastatic cancer from any solid tumor
• Planned, ongoing, or recently treated patient (within the past 30 days) with chemotherapy, immunotherapy, and/or intravenous targeted biologic therapy
• No previous use of appetite stimulants
• All patients must sign study specific informed consent prior to being included in the study
• No contraindication to appetite stimulants

You may not qualify if…

• Patient <18 years old
• Contraindication to appetite stimulants

Where it is running

• Montefiore Hospital — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.